122 related articles for article (PubMed ID: 12421501)
21. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
22. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
[TBL] [Abstract][Full Text] [Related]
23. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
24. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
[TBL] [Abstract][Full Text] [Related]
25. [Construction of recombinant adenovirus vector expressing shRNAs targeting COX-2, AKT1 and PIK3R1 gene and its inhibition effect on proliferation of human gastric adenocarcinoma].
Fu YC; Zhang J; Zhang KR; Zhang QY; Kang CS; Wang T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):383-7. PubMed ID: 20017300
[TBL] [Abstract][Full Text] [Related]
26. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma.
Ohno R; Yoshinaga K; Fujita T; Hasegawa K; Iseki H; Tsunozaki H; Ichikawa W; Nihei Z; Sugihara K
Cancer; 2001 May; 91(10):1876-81. PubMed ID: 11346869
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.
Sung JJ; Leung WK; Go MY; To KF; Cheng AS; Ng EK; Chan FK
Am J Pathol; 2000 Sep; 157(3):729-35. PubMed ID: 10980112
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
Akhtar M; Cheng Y; Magno RM; Ashktorab H; Smoot DT; Meltzer SJ; Wilson KT
Cancer Res; 2001 Mar; 61(6):2399-403. PubMed ID: 11289104
[TBL] [Abstract][Full Text] [Related]
30. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
31. [The effect of siRNA on inhibiting cyclooxygenase-2 gene expression in gastric adenocarcinoma cell].
Wang T; Kang CS; Wang BM; Zhang QY
Zhonghua Nei Ke Za Zhi; 2008 Feb; 47(2):129-32. PubMed ID: 18683800
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 expression during carcinogenesis in the human stomach.
van Rees BP; Saukkonen K; Ristimäki A; Polkowski W; Tytgat GN; Drillenburg P; Offerhaus GJ
J Pathol; 2002 Feb; 196(2):171-9. PubMed ID: 11793368
[TBL] [Abstract][Full Text] [Related]
33. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.
Fantappiè O; Masini E; Sardi I; Raimondi L; Bani D; Solazzo M; Vannacci A; Mazzanti R
Hepatology; 2002 Apr; 35(4):843-52. PubMed ID: 11915030
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis.
Tsuji S; Tsujii M; Kawano S; Hori M
J Exp Clin Cancer Res; 2001 Mar; 20(1):117-29. PubMed ID: 11370818
[TBL] [Abstract][Full Text] [Related]
35. [Effects of antisense human telomerase RNA on growth of human gastric cancer cells].
Zhang F; Zhang X; Fan D; Deng Z; Yan y ; Wu H
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):367-9. PubMed ID: 11866938
[TBL] [Abstract][Full Text] [Related]
36. [Inhibition effect of aspirin on the growth of gastric cancer and the mechanism there-in involved].
Wang C; Tang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):468-71. PubMed ID: 12910692
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of angiogenesis in pancreatic carcinoma by cyclooxygenase-2 antisense oligodeoxynucleotides].
Wang XP; Xie CG; Dong YW; Zhang RL; Wu LY; Wu K
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1501-4. PubMed ID: 14521730
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
Song SH; Jong HS; Choi HH; Inoue H; Tanabe T; Kim NK; Bang YJ
Cancer Res; 2001 Jun; 61(11):4628-35. PubMed ID: 11389100
[TBL] [Abstract][Full Text] [Related]
39. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
[TBL] [Abstract][Full Text] [Related]
40. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]